Fig. 3

Represent a comparison of IC50 (µM) for compounds 4a, 6a, 7a, 9a, 10a, 13a, 14a and Vinblastine against hepatocellular carcinoma cells lines (HepG-2)
Represent a comparison of IC50 (µM) for compounds 4a, 6a, 7a, 9a, 10a, 13a, 14a and Vinblastine against hepatocellular carcinoma cells lines (HepG-2)